FDA Recall Terminated

Orthopedic Salvage System (OSS) Porous Stem, Item No. 150394

Recall: Z-0590-2019 · Initiated October 10, 2018

Recall

Recall Number
Z-0590-2019
Event Number
81528
Firm
Zimmer Biomet, Inc.
FEI Number
1825034
Product Code
KRO
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
October 10, 2018
Terminated
April 28, 2020
Address
56 E Bell Dr, Warsaw, IN, 46582-6989

Description

Orthopedic Salvage System (OSS) Porous Stem, Item No. 150394

Reason

Zimmer Biomet is conducting a lot specific medical device recall for two lots of the Orthopedic Salvage System (OSS) and the Comprehensive Shoulder System. The investigation determined that the Mini Humeral Stem is potentially labeled as the Bowed IM Stem lot. The associated risk of this product issue is a potential extension of surgery <30 minutes if a replacement is readily available.

Action

On October 10, 2018, the firm notified affected customers via Urgent Medical Device Recall letters. Customers were advised of the product issue. Distributors were asked to take the following actions: 1. Review this notification and ensure that affected team members are aware of the contents. 2. Immediately locate and quarantine affected product in your inventory. 3. If the affected product is located at a hospital, remove the product from the hospital and provide the Risk Manager Recall Notice to the hospital and request that they sign the Certificate of Acknowledgement. 4. Immediately return all affected product from your distributorship and from affected hospitals within your territory along with hospital Certificate of Acknowledgement. a. For each return, complete Attachment 1 Inventory Return Certification Form and send to [email protected] within three (3) days. b. For each return, send a copy of Attachment 1 to [email protected]. c. Include a hardcopy of Attachment 1 in each carton of your return shipment for immediate processing. d. Mark RECALL on the outside of the returned cartons. 5. Return the Additional Accounts form to [email protected]. a. Review the list of hospitals included with the email notification sent to your facility. b. Identify whether there are any additional hospitals that Zimmer Biomet is not aware of and list these accounts on the Additional Accounts form. Please provide the form in Excel format. c. If there are no additional accounts to notify, please indicate that there are no additional accounts, or indicate None or NA on the form. Hospital Risk Managers were asked to take the following actions: 1. Review this notification and ensure that affected personnel are aware of the contents. 2. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine all affected product. Your

Distribution

Distributed to accounts in IN, MD, MO, MS, and NM.

Quantity

3 total